Nicholas Investment Partners’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-31,889
| Closed | -$4.47M | – | 245 |
|
|
2018
Q4 | $4.47M | Sell |
31,889
-356
| -1% | -$54K | 0.48% | 67 |
|
|
2018
Q3 | $5.51M | Sell |
32,245
-172
| -0.5% | -$28.9K | 0.44% | 74 |
|
|
2018
Q2 | $5.62M | Buy |
+32,417
| New | +$4.87M | 0.4% | 73 |
|
|
2017
Q4 | – | Sell |
-58,921
| Closed | -$5.43M | – | 285 |
|
|
2017
Q3 | $5.43M | Sell |
58,921
-3,889
| -6% | -$302K | 0.38% | 75 |
|
|
2017
Q2 | $5.04M | Buy |
+62,810
| New | +$3.48M | 0.36% | 85 |
|
|
2016
Q4 | – | Sell |
-67,655
| Closed | -$1.77M | – | 364 |
|
|
2016
Q3 | $1.77M | Hold |
67,655
| – | – | 0.12% | 267 |
|
|
2016
Q2 | $1.57M | Buy |
67,655
+11,010
| +19% | +$274K | 0.11% | 272 |
|
|
2016
Q1 | $1.55M | Buy |
56,645
+92
| +0.2% | +$1.93K | 0.11% | 261 |
|
|
2015
Q4 | $1.61M | Buy |
56,553
+2,172
| +4% | +$58.3K | 0.11% | 266 |
|
|
2015
Q3 | $951K | Sell |
54,381
-8,245
| -13% | -$161K | 0.07% | 281 |
|
|
2015
Q2 | $1.13M | Sell |
62,626
-20,111
| -24% | -$275K | 0.07% | 282 |
|
|
2015
Q1 | $1.03M | Buy |
82,737
+22,232
| +37% | +$277K | 0.06% | 290 |
|
|
2014
Q4 | $711K | Sell |
60,505
-12,836
| -18% | -$150K | 0.04% | 292 |
|
|
2014
Q3 | $963K | Buy |
+73,341
| New | +$952K | 0.06% | 284 |
|
Other funds holding LOXO
Nicholas Investment Partners's LOXO Position: Q1 2019 in Review
Nicholas Investment Partners sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 31,889 shares — an estimated $4.47M sold.
Nicholas Investment Partners first reported a position in LOXO in Q3 2014 and held it in 14 quarters. The position peaked at $5.62M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.
- Nicholas Investment Partners reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
- Nicholas Investment Partners sold 31,889 Loxo Oncology, Inc shares in Q1 2019, an estimated $4.47M.
- Nicholas Investment Partners first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 14 quarters.
- Nicholas Investment Partners's Loxo Oncology, Inc position peaked at $5.62M in Q2 2018.
- 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.
Based on Nicholas Investment Partners's 13F filing for Q1 2019, filed 15 May 2019.